奧園美谷(000615.SZ):與KD Medical簽署戰略合作協議
格隆匯 4 月 21日丨奧園美谷(000615.SZ)公佈,2021年4月21日,公司全資子公司廣州奧美產業研究有限公司(“廣州奧美”)與KD Medical,co.,ltd. (“KD Medical”)簽署《戰略合作協議》,就廣州奧美與KD Medical美麗健康產業合作事宜達成初步意向。
KD Medical2016年成立於韓國首爾,是一家專注於醫療美容用醫療器械製造銷售,醫療美容用活性原料開發與研究的科技型公司。主營溶脂針,動能素,PDRN,注射用透明質酸鈉等產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.